Revenue (USD, thousands)

Cost of Revenue (USD, thousands)

Gross Profit (USD, thousands)

Research and Development Expense (USD, thousands)

Sales and Marketing Expense (USD, thousands)

General and Administrative Expense (USD, thousands)

Total Operating Expenses (USD, thousands)

Loss from Operations (USD, thousands)

Interest Income and Other Income (Expense), Net (USD, thousands)

Loss Before Provision for Income Taxes (USD, thousands)

Provision for Income Taxes (USD, thousands)

Net Loss (USD, thousands)

17a4744741338bfa48f0fa9a859bf542c4c77370decd302e6609f99e326fe02a

Net loss (USD, thousands)

Depreciation and amortization (USD, thousands)

Stock-based compensation expense (USD, thousands)

Other non-cash charges (USD, thousands)

Connected device costs (USD, thousands)

Net cash used in operating activities (USD, thousands)

Purchase of property and equipment (USD, thousands)

Investing other (USD, thousands)

Net cash used in investing activities (USD, thousands)

Proceeds from issuance of common stock in connection with equity compensation plans (USD, thousands)

Payment of principal on finance leases (USD, thousands)

Net cash provided by (used in) financing activities (USD, thousands)

Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash (USD, thousands)

Net decrease in cash, cash equivalents, and restricted cash (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventories (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Deferred commissions (USD, thousands)

Other assets, non-current (USD, thousands)

Accounts payable and other liabilities (USD, thousands)

Deferred revenue (USD, thousands)

Operating lease liabilities, net (USD, thousands)

Cash, cash equivalents, and restricted cash, beginning of period (USD, thousands)

Cash, cash equivalents, and restricted cash, end of period (USD, thousands)

58d85372ccaa655ac5b6f517cfd82750b9b665f6bc0128e2de268219cc5408c0

The sharp decline in **Cash and Cash Equivalents** in Q4 2024 was driven by a combination of factors. **Net cash used in operating activities** increased significantly to **$(41.9) million** compared to the previous period's **$(4.4) million** due to higher operating losses and changes in working capital. Additionally, a one‑time **$60.0 million legal settlement payment** for lease-related litigation and **capital expenditures** of **$(2.1) million** further contributed to the reduction, despite generating **$16.0 million** in adjusted free cash flow.  **[0001642896-24-000008_samsaraepr-q42024.htm:0]** **[0001642896-24-000008_samsaraepr-q42024.htm:12]** 

What drove the sharp decline in Cash and cash equivalents in Q4 2024?

The significant jump in **Total liabilities** in Q4 2024 is primarily driven by an **increase in deferred revenue** (both current and non-current) and **higher accounts payable**. Deferred revenue increased by **$126,256 thousand** in the current period and by **$12,665 thousand** for non-current, totaling an increase of **$138,921 thousand**, reflecting higher customer prepayments for services yet to be delivered. Additionally, accounts payable grew by **$16,137 thousand**, further contributing to the rise. These factors were only partially offset by a decrease in operating lease liabilities, leading to an overall rise of **$140,709 thousand** in the reported liabilities.  **[0001642896-24-000016_iot-20240203.htm:132]** **[0001642896-24-000016_iot-20240203.htm:132]** 

Why did Total liabilities jump significantly in Q4 2024?

7c256008acb6de7888b33682075632eda5739942f43af7861899cbd41de556bd

Cash and cash equivalents (USD, thousands)

Short-term investments (USD, thousands)

Connected device costs, current (USD, thousands)

Total current assets (USD, thousands)

Restricted cash (USD, thousands)

Long-term investments (USD, thousands)

Property and equipment, net (USD, thousands)

Operating lease right-of-use assets (USD, thousands)

Connected device costs, non-current (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Accrued compensation and benefits (USD, thousands)

Deferred revenue, current (USD, thousands)

Operating lease liabilities, current (USD, thousands)

Total current liabilities (USD, thousands)

Deferred revenue, non-current (USD, thousands)

Operating lease liabilities, non-current (USD, thousands)

Other liabilities, non-current (USD, thousands)

Total liabilities (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive income (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders’ equity (USD, thousands)

Total liabilities and stockholders’ equity (USD, thousands)

877c32d0120628d648c242a9ece3743831399f3ea32e35d19e61ac819e9bbd3b

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

b6cccde243b540cfe77ce6d5e962ef295f5e7b40114002df2c11570d8c2e7677

Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

Selling, General, and Administrative Expenses (SG&A) (USD, thousands)

Research and Development (R&D) (USD, thousands)

Depreciation and Amortization (D&A) (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

1372b0b055e2c6d8188f3fe072a61f7d1a4ee4f76df3d5e8298f0fc84991a71a

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

44ccb3defa77dbb13ed6d9e57b73b2352aa7a68eb00d8421e5fe6b6a5a9d4a2f

Subscription Revenue

Other Revenue

Total Revenue

e0530f4a0b1020d671da792405fff598a5c400739d9399809aec022ed4920e71

United States

Other

b105c6dcd52299609e16afe39201972f392cd4628e53309611cca6e3bb8498d8

Samsara (IOT)

Financials